Thus, PDTC treatment reversed pain sensitivity and downregulated Scn9a and Scn10a, demonstrating that NF-κB contributes to pain hypersensitivity through regulating expression of Scn9a and Scn10a in DRGs of SMA mice. Here, SCN9A is linked to proximal spinal muscular atrophy.